Welcome to our dedicated page for Aurora Spine news (Ticker: ASAPF), a resource for investors and traders seeking the latest updates and insights on Aurora Spine stock.
Aurora Spine Corporation (ASAPF) generates a steady stream of news around its spinal implant platforms, biologics portfolio, and participation in medical and investor events. The company’s releases highlight developments in minimally invasive spine surgery, interventional pain management, and bone density–matched implant technology.
Recent announcements emphasize Aurora Spine’s DEXA Technology platform, including the DEXA-C cervical fusion system and the DEXA-L anterior lumbar interbody fusion device, which the company describes as bone-mimicking implants engineered to match a patient’s bone density and quality. Other news focuses on the SiLO Sacroiliac Joint Fusion System, which Aurora reports has been used in more than 2,500 procedures, and the AERO Lumbar Fusion System, a minimally invasive facet fusion device cleared for use from C2 to S1.
Investors and clinicians following ASAPF news will also see updates on Aurora Biologics, a division dedicated to allograft-based biologic solutions designed to support spinal fusion and work in concert with the company’s mechanical implants. Patent issuances, such as those covering the ZIP implant family and bone density scan–matched orthopedic implants, further illustrate Aurora’s focus on intellectual property around spinal implant design.
This news feed captures product launches, clinical usage milestones, conference participation at meetings like NASS and ASPN, and scheduled financial result releases and investor presentations. Users can monitor these updates to understand how Aurora Spine presents the evolution of its spine technologies, surgeon adoption, and broader corporate activities over time.
Aurora Spine Corporation (TSXV: ASG, OTCQB: ASAPF) will participate in the Lytham Partners Spring 2022 Investor Conference from April 4-7, 2022. The Company will host a panel discussion titled Simplifying the Complex – A Panel Discussion with Doctors that use Aurora Products on April 4 at 11:00 am ET, available on its website. Additionally, management will engage in virtual one-on-one meetings throughout the event. The webcast will be archived for later viewing. Aurora Spine specializes in innovative, minimally invasive spinal implant technologies.
Aurora Spine Corporation has achieved a significant milestone with the world's first surgical implantation of the DEXA-C patient matched implant at Cypress Pointe Surgical Hospital in Louisiana. This innovative device customizes spinal implants based on a patient's bone density, enhancing surgical outcomes and expanding access for older patients. Supported by peer-reviewed research, DEXA-C aims to reduce implant subsidence and improve fusion success rates. With the integration of Echolight technology, surgeons can now ensure the right implant density is selected for each patient, marking a transformative step in personalized spine surgery.
Aurora Spine Corporation (TSXV: ASG | OTCQB: ASAPF) announced a joint co-marketing agreement with Echolight Medical on February 24, 2022. This partnership focuses on integrating Aurora’s DEXA Technology-based spinal implants with Echolight’s radiation-free EchoS densitometer for assessing bone health. The collaboration aims to enhance patient care by providing quick and accurate bone quality analysis, which will aid in selecting appropriate spinal implants. Both companies anticipate improved healthcare access and increased support for orthopedic and spinal treatments.
Aurora Spine Corporation reports strong preliminary results for Q4 and FY2021, with a projected revenue increase of approximately 23% to about $3.0 million and over $10.5 million, respectively. Sales of ZIP® products surged by 145%, while SiLO™ SI Joint fusion devices contributed 10% to Q4 sales, up 84%. The company has introduced innovative products including the APOLLO™ cervical plate and DEXA-C™ cervical interbody system, expected to enhance market share. The U.S. SI Joint market alone is valued at $2.6 billion, presenting significant opportunities for growth.
Aurora Spine Corporation has received a 'Notice of Allowance' from the USPTO for its patent on the ZIPFlex, a minimally invasive interspinous implant. This innovation aims to enhance spinal surgery outcomes by allowing for either motion preservation or fusion during operations. CEO Trent Northcutt emphasized the patent's potential to differentiate the company in the market and increase shareholder value. The new product aims to fill a significant gap in spine surgery tools, reflecting Aurora's commitment to innovative solutions.
Aurora Spine Corporation (OTCQB: ASAPF) announced the successful completion of its first anterior cervical discectomy and fusion procedures using the proprietary APOLLO Anterior Cervical Plate (ACP) system. Conducted by Dr. Sebastian Koga, these procedures highlight the system's innovative design and functionality, emphasizing its potential to enhance surgical outcomes. The APOLLO system includes advanced features like Hyper-Angulation™ screws and a titanium alloy construction. This launch marks a strategic milestone as the company prepares to introduce additional products under its DEXA Technology platform.
Aurora Spine Corporation (OTCQB: ASAPF) announced a peer-reviewed clinical publication focused on its DEXA-C spinal interbody implant. The article highlights the implant’s design, which simulates human bone structure and addresses the needs of patients with varying bone mineral density, including osteoporosis. This technology aims to improve surgical outcomes by offering personalized solutions for spinal fusion surgeries. Aurora plans to continue research and is set to begin implanting DEXA-C shortly, signaling a potential innovation in the spinal implant market.
Aurora Spine Corporation (TSXV: ASG, OTCQB: ASAPF) will participate in the Lytham Partners Winter 2021 Investor Conference from December 13-16, 2021. The company will host a webcasted Fireside Chat on December 13 at 11:00 am ET, discussing its vision for 2022, and will conduct one-on-one virtual investor meetings. Interested parties can watch the webcast on Aurora Spine's website or via a provided link. The company specializes in innovative spinal surgery devices aimed at improving surgical outcomes.
Aurora Spine Corporation (TSXV: ASG, OTCQB: ASAPF) has partnered with PRIA Healthcare to improve patient access to its innovative spinal devices, including ZIP® and SiLO™. PRIA brings 10 years of medtech experience, assisting companies in navigating insurance systems to facilitate patient access to emerging medical technologies. Aurora's leadership expresses confidence in PRIA's capabilities, emphasizing a shared commitment to enhancing patient outcomes through advanced medical solutions.
Aurora Spine Corporation (TSXV: ASG, OTCQB: ASAPF) will participate in the Lytham Partners Fall 2021 Investor Conference from October 5-7, 2021. The President and CEO, Trent Northcutt, is set to present on October 5 at 2:45 PM ET. A webcast of the presentation will be accessible on the company’s website, and it will be archived for later viewing. Northcutt, along with CFO Chad Clouse, will also hold one-on-one meetings during the event. The company focuses on innovative spinal implant technologies and is anticipating commercialization of new products in the upcoming quarters.